Multiple sclerosis (MS) is a chronic illness affecting the central nervous system (CNS) of young adults, with an increasing disease burden over time. Classically regarded as an autoimmune disease sustained by a T-helper mediated inflammatory pathway of demyelination, it is now apparent that a more insidious degenerative process, in which axonal damage and neuronal death play a central role, may also be present. 1 Among patients and within patients over time, the combination of these pathological mechanisms promotes and sustains the progression of irreversible physical and cognitive disability.Magnetic resonance imaging (MRI) provides a sensitive tool for noninvasively studying pathological mechanisms in diseased brains. In the clinical setting, MS imaging is performed as a multisequence protocol. Pre-and post-contrast T1 weighted spin echo (SE) images as well as T2 weighted SE images and T2 fluid-attenuated inversion recovery (FLAIR) images are routinely used. These imaging sequences, commonly defined as conventional MRI techniques, allow identification of the distinctive multiple lesions.However, the gathered MRI-derived indices of disease poorly reflect the extent of patients' disability as quantified by clinical measures. Researchers use the term "clinical-MRI" paradox to describe such a disconnection 2 and ascribe several factors to its existence. Among them is the limited pathological specificity of MRI, ie, visible lesions do not mirror the heterogeneity of the biological mechanisms sustaining their pathology. Conversely, visualizing and characterizing the heterogeneity of brain parenchymal lesions in vivo is a fundamental prerequisite for following the disease's natural evolution over time, monitoring the effect of the administered drugs and developing new therapeutic strategies. An additional limitation of conventional MRI sequences is their inability to identify the effects of MS worsening beyond visible lesions or detecting pre-lesion formation in CNS tissue appearing as normal. For many years, using non-conventional quantitative MRI techniques 3 greatly aided in uncovering and quantifying pathology of normal-appearing CNS tissue. Non-conventional MRI techniques, however, may be labor-intensive, thus often difficult to use in daily clinical practice.In an attempt to overcome those MRI limitations, in the present paper Kataoka et al 4 propose using post-contrast, ie, gadolinium-diethylenetriamine penta-acetic acid (Gd-DTPA), FLAIR to identify and characterize, in greater detail, active lesions of MS patients. As opposed to non-conventional MRI techniques, the combination of FLAIR and Gd can be easily implemented. Thus, although the work reports a small cohort of patients and the findings do not allow any definite conclusion, the proposal of the authors to consider post-contrast FLAIR image as part of the MS imaging protocol is intriguing and worth of further larger investigations.By consensus, active lesions are regarded as the first in vivo recognizable event of MS and represent foci of inflammatory act...